DDX5 and hepatocellular carcinoma: ATAC-seq of DDX5KD and wild-type DDX5 cells further identified that DDX5 inhibits Wnt signaling by affecting chromatin accessibility of genes involved in Wnt signaling, and DDX5 may be a negative regulator of Wnt signalling and hepatocyte reprogramming in HCC (45).